Drug targeting using solid lipid nanoparticles

Chemistry and Physics of Lipids

Volumn 181, Issue , 2014, Pages 56-61

  Rostami, Elham ^a   Kashanian, Soheila ^b   Azandaryani, Abbas H ^b,c   Faramarzi, Hossain ^a   Dolatabadi, Jafar Ezzati Nazhad ^d   Omidfar, Kobra ^e  

^a LARESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b RAZI UNIVERSITY   (Iran)

^c KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibody; Drug targeting; Magnetic SLN; pH sensitive; Solid lipid nanoparticle

Indexed keywords

ANTIBODY SOLID LIPID NANOPARTICLE; CATIONIC SOLID LIPID NANOPARTICLE; MAGNETIC NANOPARTICLE; MAGNETIC SOLID LIPID NANOPARTICLE; PH SENSITIVE SOLID LIPID NANOPARTICLE; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG; ANTIBODY; DRUG CARRIER; LIPID; NANOPARTICLE;

DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; NANOMEDICINE; NANOPHARMACEUTICS; PRIORITY JOURNAL; REVIEW; CHEMISTRY; HUMAN; METABOLISM; NANOTECHNOLOGY; PH; PROCEDURES;

ANTIBODIES; DRUG CARRIERS; HUMANS; HYDROGEN-ION CONCENTRATION; LIPIDS; NANOPARTICLES; NANOTECHNOLOGY;

EID: 84899689651     PISSN: 00093084     EISSN: 18732941     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2014.03.006     Document Type: Review

References (59)

1. C. Alexiou, R. Jurgons, R. Schmid, A. Hilpert, C. Bergemann, F. Parak, and H. Iro In vitro and in vivo investigations of targeted chemotherapy with magnetic nanoparticles J. Magn. Magn. Mater. 293 1 2005 389 393 (Pubitemid 40608956)
2. S.C. Alley, N.M. Okeley, and P.D. Senter Antibody-drug conjugates: targeted drug delivery for cancer Curr. Opin. Chem. Biol. 14 4 2010 529 537
3. M. BabincovaÍ, P. Cicmanec, V. Altanerova, C. Altaner, and P. Babinec AC-magnetic field controlled drug release from magnetoliposomes: design of a method for site-specific chemotherapy Bioelectrochemistry 55 1-2 2002 17 19 (Pubitemid 34084742)
4. A. Beduneau, P. Saulnier, and J.-P. Benoit Active targeting of brain tumors using nanocarriers Biomaterials 28 33 2007 4947 4967 (Pubitemid 47362345)
5. P. Blasi, S. Giovagnoli, A. Schoubben, M. Ricci, and C. Rossi Solid lipid nanoparticles for targeted brain drug delivery Adv. Drug Deliv. Rev. 59 6 2007 454 477 (Pubitemid 47259226)
6. G. Blume, G. Cevc, M.D.J.A. Crommelin, I.A.J.M. Bakker-Woudenberg, C. Kluft, and G. Storm Specific targeting with poly (ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times Biochim. Biophys. Acta 1149 1 1993 180 184 (Pubitemid 23186318)
7. L. Brannon-Peppas, and J.O. Blanchette Nanoparticle and targeted systems for cancer therapy Adv. Drug Deliv. Rev. 64 11 2012 206 212
8. C. Carrillo, N. Hernández, E. García-Montoya, P. Pérez-Lozano, J.M. Suñé-Negre, J.R. Tico, C. Suñé, and M. Miñarro DNA delivery via cationic solid lipid nanoparticles (SLNs) Eur. J. Pharm. Sci. 49 2 2013 157 165
9. G. Casi, and D. Neri Antibody-drug conjugates: basic concepts, examples and future perspectives J. Control. Release 161 2 2012 422 428
10. Y.C. Kuo, and H.H. Chen Effect of nanoparticulate poly butyl cyanoacrylate and methyl methacrylate-sulfo propyl methacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier Int. J. Pharm. 327 1-2 2006 160 169
11. K. Cho, X. Wang, S. Nie, Z. Chen, and D.M. Shin Therapeutic nanoparticles for drug delivery in cancer Clin. Cancer Res. 14 5 2008 1310 1316 (Pubitemid 351413909)
12. S.M. Demos, S. Dagar, M. Klegerman, A. Nagaraj, D.D. Mcpherson, and H. Onyuksel In vitro targeting of acoustically reflective immunoliposomes to fibrin under various flow conditions J. Drug Target. 5 6 1998 507 518 (Pubitemid 28499684)
13. A.V. Heydenreich, R. Westmeier, N. Pedersen, H.S. Poulsen, and H.G. Kristensen Preparation and purification of cationic solid lipid nanospheres-effects on particle size, physical stability and cell toxicity Int. J. Pharm. 254 3 2003 83 87 (Pubitemid 36259816)
14. S. Hirosue, I.C. Kourtis, A.J. Van der Vlies, J.A. Hubbell, and M.A. Swartz Antigen delivery to dendritic cells by poly (propylene sulfide) nanoparticles with disulfide conjugated peptides: cross-presentation and T cell activation Vaccine 28 50 2010 7897 7906
15. M.-H. Hsu, and Y.-C. Su Iron-oxide embedded solid lipid nanoparticles for magnetically controlled heating and drug delivery Biomed. Microdevices 10 6 2008 785 793
16. L.D. Hu, X. Tang, and F.D. Cui Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs J. Pharm. Pharmacol. 56 13 2004 1527 1535 (Pubitemid 39601993)
17. M. Igartuaa, P. Saulnier, B. Heurtault, B. Pech, J.E. Proust, J.L. Pedraz, and J.P. Benoit Development and characterization of solid lipid nanoparticles loaded with magnetite Int. J. Pharm. 233 1-2 2002 149 157 (Pubitemid 34230427)
18. A. Jordan, R. Scholz, P. Wust, H. FaKhling, and R. Felix Magnetic fluid hyperthermia (MFH): cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles J. Magn. Magn. Mater. 201 1-3 1999 413 419
19. M.D. Joshi, and R.H. Müller Lipid nanoparticles for parenteral delivery of actives Eur. J. Pharm. Biopharm. 71 2 2009 161 172
20. M.S. Kamble, K.K. Vaidya, A.V. Bhosale, and P.D. Chaudhari Solid lipid nanoparticles and nanostructure lipid carriers - an overview Int. J. Pharm. Chem. Biol. Sci. 2 4 2012 681 691
21. S. Kashanian, A.H. Azandaryani, and K. Derakhshande New surface-modified solid lipid nanoparticles using N-glutarylphosphatidylethanolamine as the outer shell Int. J. Nanomed. 6 1 2011 1 9
22. E. Kluza, S.Y. Yeo, S. Schmid, D.W.J. Van der Schaft, R.W. Boekhoven, R.M. Schiffelers, G. Storm, G.J. Strijkers, and K. Nicolay Anti-tumor activity of liposomal glucocorticoids: the relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity J. Control. Release 151 1 2011 10 17
23. O.M. Koo, I. Rubinstein, and H. Onyuksel Role of nanotechnology in targeted drug delivery and imaging: a concise review Nanomedicine 1 3 2005 193 212 (Pubitemid 43963632)
24. Y.C. Kuo, and H.H. Chen Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles Int. J. Pharm. 365 1-2 2009 206 213
25. Y.-C. Kuo, and H.-F. Ko Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles Biomaterials 34 20 2013 4818 4830
26. Y.C. Kuo, and F.L. Su Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate- sulfopropylmethacrylate, and solid lipid nanoparticles Int. J. Pharm. 340 1-2 2007 143 152
27. S.B. Lim, A. Banerjee, and H. Önyüksel Improvement of drug safety by the use of lipid-based nanocarriers J. Control. Release 163 1 2012 34 45
28. D. Liu, C. Liu, W. Zou, and N. Zhang Enhanced gastrointestinal absorption of N3-O-toluylfluorouracil by cationic solid lipid nanoparticles J. Nanopart. Res. 12 1 2010 975 984
29. Y. Lu, J. Huang, H. Wang, X. Lou, M. Liao, L. Hong, R. Tao, M.M. Ahmed, and C. Shan Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles Biomaterials 35 1 2014 530 537
30. B. Mandal, H. Bhattacharjee, N. Mittal, H. Sah, P. Balabathula, L.A. Thoma, and G.C. Wood Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform Nanomedicine 9 4 2013 474 491
31. S.M. Martins, B. Sarmento, C. Nunes, M. Lcio, S. Reis, and D.C. Ferreira Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration Eur. J. Pharm. Biopharm. 85 3 2013 488 502
32. W. Mehnert, and K. Mader Solid lipid nanoparticles: production, characterization and applications Adv. Drug Deliv. Rev. 47 2-3 2001 165 196 (Pubitemid 32324113)
33. A.A. Mokhtarieh, S. Cheong, S. Kim, B.H. Chung, and M.K. Lee Asymmetric liposome particles with highly efficient encapsulation of siRNA and without nonspecific cell penetration suitable for target-specific delivery Biochim. Biophys. Acta 1818 7 2012 1633 1641
34. P. Moroz, S.K. Jones, and B.N. Gray Status of hyperthermia in the treatment of advanced liver cancer J. Surg. Oncol. 77 4 2001 259 269 (Pubitemid 32744195)
35. R.H. Muller, and C.M. Keck Challenges and solutions for the delivery of biotech drugs - a review of drug nanocrystal technology and lipid nanoparticles J. Biotechnol. 113 1-3 2004 151 170 (Pubitemid 39237077)
36. R.H. Muller, S. Maa, beta en, H. Weyhers, F. Specht, and J.S. Lucks Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles Int. J. Pharm. 138 1 1996 85 94 (Pubitemid 26241925)
37. T. Neuberger, B. Schopf, H. Hofmann, M. Hofmann, and B. Von Rechenberg Super paramagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system J. Magn. Magn. Mater. 293 1 2005 483 496 (Pubitemid 40608969)
38. C. Olbrich, U. Bakowsky, C.M. Lehr, R.H. Müller, and C. Kneuer Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA J. Control. Release 77 3 2001 345 355 (Pubitemid 33145485)
39. X. Pang, F. Cui, J. Tian, J. Chen, J. Zhou, and W. Zhou Preparation and characterization of magnetic solid lipid nanoparticles loaded with ibuprofen Asian J. Pharm. Sci. 4 2 2009 132 137
40. D. Papahadjopoulos, T.M. Allen, A. Gabizon, E. Mayhew, K. Matthay, S.K. Huang, K.D. Lee, M.C. Woodle, D.D. Lasic, C. Redemann, and F.J. Martin Sterically stabilized liposomes: improvements in pharmaco kinetics and antitumor therapeutic efficacy Proc. Natl. Acad. Sci. U.S.A. 88 10 1991 11460 11464 (Pubitemid 21916061)
41. R. Parhi, and P. Suresh Production of solid lipid nanoparticles-drug loading and release mechanism J. Chem. Pharm. Res. 2 1 2010 211 227
42. D. Peer Immunotoxicity derived from manipulating leukocytes with lipid-based nanoparticles Adv. Drug Deliv. Rev. 64 15 2012 1738 1748
43. D. Pissuwan, T. Niidome, and M.B. Cortie The forth coming applications of gold nanoparticles in drug and gene delivery systems J. Control. Release 149 1 2011 65 71
44. B. Saha, J. Bhattacharya, A. Mukherjee, A.K. Ghosh, C.R. Santra, A.K. Dasgupta, and P. Karmakar In vitro structural and functional evaluation of gold nanoparticles conjugated antibiotics Nanoscale Res. Lett. 2 12 2007 614 622 (Pubitemid 350178471)
45. R.K. Subedi, K.W. Kang, and H.K. Choi Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin Eur. J. Pharm. Sci. 37 3-4 2009 508 513
46. J. Sudimack, and R.J. Lee Targeted drug delivery via the folate receptor Adv. Drug Deliv. Rev. 41 2 2000 147 162 (Pubitemid 30122955)
47. D. Sutton, N. Nasongkla, E. Blanco, and J. Gao Functionalized micellar systems for cancer targeted drug delivery Pharm. Res. 24 6 2007 1029 1046 (Pubitemid 46798882)
48. V.P. Torchilin Micellar nanocarriers: pharmaceutical perspectives Pharm. Res. 24 1 2007 1 16 (Pubitemid 44902565)
49. E. Ugazio, R. Cavalli, and M.R. Gasco Incorporation of cyclosporin A in solid lipid nanoparticles (SLN) Int. J. Pharm. 241 2 2002 341 344 (Pubitemid 34718035)
50. M. Uner, and G. Yener Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives Int. J. Nanomed. 2 3 2007 289 300 (Pubitemid 350047774)
51. M. Wang, and M. Thanou Targeting nanoparticles to cancer Pharm. Res. 62 2 2010 90 99
52. T. Wang, F.M. Kievit, O. Veiseh, H. Arami, Z.R. Stephen, C. Fang, Y. Liu, R.G. Ellenbogen, and M. Zhang Targeted cell uptake of a noninternalizing antibody through conjugation to iron oxide nanoparticles in primary central nervous system lymphoma World Neurosurg. 80 1-2 2013 134 141
53. P. Wasutrasawat, H. Al-Obaidi, S. Gaisford, M.J. Lawrence, and W. Warisnoicharoen Drug solubilisation in lipid nanoparticles containing high melting point triglycerides Eur. J. Pharm. Biopharm. 85 3 2013 365 371
54. H.L. Wong, R. Bendayan, A.M. Rauth, Y. Li, and X.Y. Wu Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles Adv. Drug Deliv. Rev. 59 6 2007 491 504 (Pubitemid 47259227)
55. S.D. Xiang, K. Wilson, S. Day, M. Fuchsberger, and M. Plebanski Methods of effective conjugation of antigens to nanoparticles as non-inflammatory vaccine carriers Methods 60 3 2013 232 241
56. Q. Xu, S.P. Kambhampati, and R.M. Kannan Nanotechnology approaches for ocular drug delivery Middle East Afr. J. Ophthalmol. 20 1 2013 26 37
57. M.V. Yezhelyev, X. Gao, Y. Xing, A. Al-Hajj, S. Nie, and R.M. O'Regan Emerging use of nanoparticles in diagnosis and treatment of breast cancer Lancet Oncol. 7 8 2006 657 667 (Pubitemid 44143778)
58. N. Zhang, Q. Ping, G. Huang, W. Xu, Y. Cheng, and X. Han Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin Int. J. Pharm. 327 1-2 2006 153 159 (Pubitemid 44667334)
59. Z. Zhang, H. Bu, Z. Gao, Y. Huang, F. Gao, and Y. Li The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats Int. J. Pharm. 394 1-2 2010 147 153